OK SB1563

Prohibits the Oklahoma Health Care Authority from imposing more restrictive prior authorization or step therapy requirements on FDA-approved nonopioid pain medications than those applied to opioid pain medications in the Medicaid formulary

Bars Medicaid and contracted entities from denying coverage of a prescribed nonopioid pain drug in favor of an opioid drug

Authorizes carriers of state employee flexible benefit plans to adopt a preferred drug list (PDL) with the same restrictions on utilization controls for nonopioid drugs

Defines "nonopioid drug" as a medication that produces pain relief without acting on opioid receptors and has no therapeutically equivalent alternative

Takes effect January 1, 2027